CA
Candel Therapeutics
CADL·NASDAQNeedham MAFounded 201750 employees
Micro CapbiotechPublicOncology
Platform: Oncolytic Immuno
Market Cap
$0.06B
All Drugs
2
Clinical Trials
6
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (CADL)
Loading CADL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talarelsin | CAD-6802 | NDA/BLA | 2 | FXIa | Pancreatic Ca | ||
| CAD-8013 | CAD-8013 | Phase 3 | 4 | WEE1 | Ovarian CaCF |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)